[⁶⁸Ga]Ga-FAP-2286-Synthesis, Quality Control and Comparison with [¹⁸F]FDG PET/CT in a Patient with Suspected Cholangiocellular Carcinoma

• Main Authors: Anton Amadeus Hörmann (Author), Gregor Schweighofer-Zwink (Author), Gundula Rendl (Author), Kristina Türk (Author), Samuel Nadeje (Author), Kristina Haas (Author), Theresa Jung (Author), Ursula Huber-Schönauer (Author), Lukas Hehenwarter (Author), Mohsen Beheshti (Author), Christian Pirich (Author)
• Format: Book
• Published: MDPI AG, 2024-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

[⁶⁸Ga]Ga-FAP-2286 is a new peptide-based radiopharmaceutical for positron-emission tomography (PET) that targets fibroblast activation protein (FAP). This article describes in detail the automated synthesis of [⁶⁸Ga]Ga-FAP-2286 using a commercially avail...